Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced that emerging clinical data continues to support CyberKnife radiosurgery for the treatment of lung cancer, following a study published in the July 2008 issue of Clinical Lung Cancer.
(more...)